Etanercept - review of efficacy and safety after five years of clinical use
- 1 September 2004
- journal article
- review article
- Published by Future Medicine Ltd in Therapy
- Vol. 1 (1) , 11-23
- https://doi.org/10.1586/14750708.1.1.11
Abstract
No abstract availableThis publication has 56 references indexed in Scilit:
- Etanercept added to background methotrexate therapy in patients with rheumatoid arthritis: Continued observationsArthritis & Rheumatism, 2003
- Etanercept versus methotrexate in patients with early rheumatoid arthritis: Two‐year radiographic and clinical outcomesArthritis & Rheumatism, 2002
- Immune Function in Patients with Rheumatoid Arthritis Treated with EtanerceptClinical Immunology, 2002
- Guidelines for the management of rheumatoid arthritis: 2002 UpdateArthritis & Rheumatism, 2002
- A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid ArthritisNew England Journal of Medicine, 2000
- The Pharmacokinetics of Etanercept in Healthy VolunteersAnnals of Pharmacotherapy, 2000
- Methotrexate in the treatment of ankylosing spondylitisScandinavian Journal of Rheumatology, 2000
- Etanercept Therapy in Rheumatoid ArthritisAnnals of Internal Medicine, 1999
- A Trial of Etanercept, a Recombinant Tumor Necrosis Factor Receptor:Fc Fusion Protein, in Patients with Rheumatoid Arthritis Receiving MethotrexateNew England Journal of Medicine, 1999
- Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)–Fc Fusion ProteinNew England Journal of Medicine, 1997